VRIZIDE PM 60/15/500 TABLET
Generic Salt Composition: Gliclazide 60mg MR + Pioglitazone 15mg + Metformin 500mg SR
Price: ₹55 MRP: ₹91.22
Save up to 40% compared to branded medicines.
Top Brand Substitutes & Equivalents
Glyciphage-PG, Pioz-MF-G, Glicomet-GP, Tripride, Gluconorm-PG, Glimiprex-MF, Pioglit-G, Met-Glic-Pio, Tri-Diabetes, Gliclazide-Pio-Met, Zomet-PG, Diabetrol-PG, Glycomet-GP, Pio-Glic-Met, Glic-Pio-Met, Tri-Formin, Gliclazide-Plus, Met-Pio-G, Glucovance-Combo, Trio-Diabetes, Glycomet 500 SR, Glycomet 850, Glycomet 1000 SR, Cetapin 500, Cetapin 1000, Glucophage 500, Glucophage XR 1000, Obimet 500, Obimet 1000, Formin 500
Product Overview & Uses
VRIZIDE PM 60/15/500 TABLET is a potent, fixed-dose combination therapy designed for the comprehensive management of Type 2 Diabetes Mellitus. Within the Diabetes Care category, this medication is specifically formulated for patients who require more than one agent to achieve their HbA1c targets. Gliclazide 60mg MR stimulates pancreatic insulin secretion, Pioglitazone 15mg enhances peripheral insulin sensitivity, and Metformin 500mg SR reduces hepatic glucose production while improving peripheral glucose uptake. By targeting three distinct pathophysiological pathways of diabetes, VRIZIDE PM 60/15/500 TABLET provides a robust approach to glycemic regulation. It is intended for use alongside diet and exercise to ensure optimal metabolic health and reduce the risk of long-term diabetic complications.